<DOC>
	<DOCNO>NCT00169507</DOCNO>
	<brief_summary>Evaluate immunological memory induce 4 dos GSK Biologicals ' 11valent pneumococcal vaccine ; study antibody persistence 30 month 4 dose vaccination GSK Biologicals ' 11-valent pneumococcal vaccine Undeca-Pn-010 study .</brief_summary>
	<brief_title>Study Immunological Memory Induced Children Full 4 Dose Vaccination Schedule 11 Valent Pneumococcal Conjugate Vaccine Giving 1 Dose Aventis Pasteur 's 23-valent Pneumococcal Polysaccharide Vaccine ( Pneumo 23 )</brief_title>
	<detailed_description>Primed group : 50 subject previously receive 4 dos GSK Biologicals ' 11Pn-PD vaccine receive 1 dose Pneumo 23 Unprimed group ( Control ) : 50 subject receive GSK Biologicals ' Havrixâ„¢ vaccine receive 1 dose Pneumo 23</detailed_description>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Inclusion criterion : Male female participate UndecaPn010 study , part blood subset receive 4 dos GSK Biologicals ' 11PnPD vaccine , Havrix vaccine . Exclusion criterion : Use investigational nonregistered drug vaccine study vaccine within 30 day preceeding first dose study vaccine , plan use study period . Administration additional pneumococcal vaccine since study end UndecaPn010 ( 347414/010 )</criteria>
	<gender>All</gender>
	<minimum_age>31 Months</minimum_age>
	<maximum_age>57 Months</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>